Skip to main content
Search
Mose

Mose

  
Mose > Life science conference  

Life science conference

 
Home
Multiscale Molecular Modeling
MOSE Staff
Publications
Conference proceeding
Conferences & Seminars
Research projects
 
Life science conference
#YearAuthorsReferenceTopicTitle
6032018Carta A., Sanna G., Briguglio I., Madeddu S., Vitale G., Piras S., Corona P. Peana A.T., Laurini E., Fermeglia M., Pricl S., Serra A., Carta E., Loddo R., Giliberti G.2018; https://doi.org/10.1016/j.ejmech.2017.12.083 European Journal of Medicinal ChemistryLink to PDF DocumentQuinoxaline derivatives as new inhibitors of coxsackievirus B5
6022018Marson D,. Laurini E., Fermeglia M., Smith D.K., Pricl S.2018; DOI https://doi.org/10.1016/j.fluid.2017.11.005Fluid Phase EquilibriaMallard Blue binding to heparin, its SDS micelle-driven de- complexation, and interaction with human serum albumin: A combined experimental/modeling investigation
5932017Weber F, Brust P, Laurini E, Pricl S, Wünsch B2017;964:31-48Advances in Experimental Medicine and BiologyFluorinated PET tracers for molecular imaging of σ1 receptors in the central nervous system
5902017Rodrigo AC, Bromfield SM, Laurini E, Posocco P, Pricl S, Smith DK2017;53(47):6335-6338Chemical CommunicationsMorphological control of self-assembled multivalent (SAMul) heparin binding in highly competitive media
6002017Rodrigo A.C., Laurini E., Vieira V.M.P., Pricl S., Smith D.K. 2017;53,11580-11583Chemical CommunicationsEffect of buffer at nanoscale molecular recognition interfaces - electrostatic binding of biological polyanions
5912017Albanyan B, Laurini E, Posocco P, Pricl S, Smith DK2017;23(26):6391-6397Chemistry - A European JournalSelf-assembled multivalent (SAMul) polyanion binding-impact of hydrophobic modifications in the micellar core on DNA and heparin binding at the peripheral cationic ligands
5862017Wünsch B, Kokornaczyk A, Schepmann D, Yamaguchi J, Itami K, Laurini E, Fermeglia M, Pricl S2017; 12, 1070-1080 ChemMedChemThiazole-based sigma-1 receptor ligands: Diversity by late-stage C-H arylation of thiazoles, structure affinity and selectivity relationships and molecular interactions
6042017Chiarappa G., Piccolo A., Colombo I., Hasa D., Voinovich D., Moneghini M., Grassi G., Farra R., Abrami M., Posocco P., Pricl S., Grassi M.2017;17, 4072-4083Crystal Growth & DesignExploring the Shape Influence on Melting Temperature, Enthalpy, and Solubility of Organic Drug Nanocrystals by a Thermodynamic Model
6012017Briguglio I., Laurini E., Pirisi M.A., Piras S., Corona P., Fermeglia M., Pricl S., Carta A.2017;141,460-472European Journal of Medicinal ChemistryTriazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: Synthesis, in vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics
5952017Laurini E, Marson D, Fermeglia M, Pricl S2017; 244,27-50In "Handbook of experimental Pharmacology", eds. F.J Kim and G.W. Pasternak, Springer 2017Link to PDF Document3D homolgy model of sigma 1 receptor
5942017Vieira VMP, Liljeström V, Posocco P, Laurini E, Pricl S, Kostiainen MA, Smith DK B, 2017;5(2):341-347Journal of Materials ChemistryEmergence of highly-ordered hierarchical nanoscale aggregates on electrostatic binding of self-assembled multivalent (SAMul) cationic micelles with polyanionic heparin
5872017Colombo C, Belfiore A, Paielli N, De Cecco L, Canevari S, Laurini E, Fermeglia M, Pricl S, Verderio P, Bottelli S, Fiore M, Stacchiotti S, Palassini E, Gronchi A, Pilotti S, Perrone F2017; 11, 1495-1507Molecular Oncologyβ-catenin in desmoid-type fibromatosis: deep insights on the role of T41A and S45F mutations on protein structure and gene expression
5882017Andrieu C, Ziouziou H, Laurini E, Karaki S, Baylot V, Fermeglia M, Dusetti N, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P2017; 8,77317-77329 OncotargetTargeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
5892017Perfetti V, Laurini E, Aulic S, Fermeglia M, Riboni R, Lucioni M, Dallera E, Delfanti S, Pugliese L, Latteri FS, Pietrabissa A, Pricl S2017; 8:56158-56167OncotargetMolecular and functional characterization of a new 3’ end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib
5852017Genini D, Brambilla L, Laurini E, Merulla J, Civenni G, Pandit S, D'Antuono R, Perez L, Levy DE, Pricl S, Carbone GM, Catapano CV2017; 114, e4924-e4933 Proceedings of the National Academy of Science (PNAS)Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells
5792016Chan, Ching W.; Laurini, Erik; Posocco, Paola; Pricl, Sabrina; Smith, David K.2016; 52:10540-10543Chemical CommunicationsChiral recognition at self-assembled multivalent (SAMul) nanoscale interfaces – enantioselectivity in polyanion binding
5772016Fechner, LE; Albanyan, B; Vieira, VMP; Laurini, E; Posocco, P; Pricl, S; Smith, DK2016; 7:4653-4659Chemical ScienceElectrostatic binding of polyanions using self-assembled multivalent (SAMul) ligand displays – structure–activity effects on DNA/heparin binding
5732016Zampieri, Daniele; Vio, Luciano; Fermeglia, Maurizio; Pricl, Sabrina; Wünsch, Bernhard; Schepmann, Dirk; Romano, Maurizio; Mamolo, Maria Grazia; Laurini, Erik2016; 121:712-726European Journal of Medicinal ChemistryComputer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands
5712016A. Carta, I. Briguglio, S. Piras, P. Corona, R. Ibba, E. Laurini, M. Fermeglia, S. Pricl, N. Desideri, E.M. Atzori, P. La Colla, G. Collu, I. Delogu, R. Loddo2016;117: 321-334European Journal of Medicinal ChemistryLink to PDF DocumentA combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems
5662016E. Laurini, D. Marson, P. Posocco, M. Fermeglia, S. Pricl2016; 422:18-31Fluid Phase EquilibriaLink to PDF DocumentStructure and binding thermodynamics of viologen-phosphorous dendrimers to human serum albumin: a combined computational/experimental investigation.
5802016Estrada, Martín; Pérez, Concepción; Soriano, Elena; Laurini, Erik; Romano, Maurizio; Pricl, Sabrina; García, José A Morales; Pérez-Castillo, Ana; Rodríguez-Franco, María Isabel2016; 8:1191-1207Future Medicinal ChemistryNew neurogenic lipoic-based hybrids as innovative Alzheimer’s drugs with σ-1 agonism and β-secretase inhibition
5782016Weber, Frauke; Brune, Stefanie; Börgel, Frederik; Korpis, Katharina; Lange, Carsten; Bednarski, Patrick J; Laurini, Erik; Fermeglia, Maurizio; Pricl, Sabrina; Schepmann, Dirk; Wünsch, Bernhard2016; 59:5505-5519Journal of Medicinal ChemistryRigidity versus flexibility: is this an issue in S1 (sigma-1) receptor ligand affinity and activity?
5622016Beiranvand Z, Bani F, Kakanejadifard A, Laurini E, Fermeglia M, Pricl S, Adeli M.2016; 6:11266-11277.RSC AdvancesAnticancer drug delivery systems based on specific interactions between albumin and polyglicerol
5702016Chen C, Posocco P., Liu X., Cheng Q.,Laurini E., Zhou J., Liu C., Wang Y., Tang J., Dal Col V., Yu T., Giorgio S., Fermeglia M., Qu F., Liang Z., Rossi J.J., Liu M., Rocchi P., Pricl S., Peng L.2016; 12:3667-3676SmallLink to PDF DocumentMastering Dendrimer Self-Assembly for Effi cient siRNA Delivery: From Conceptual Design to In Vivo Effi cient Gene Silencing
5402015Zampieri D,, Laurin E, Vio L, Fermeglia M, Pricl S, Wuensch B, Schepmann D, Mamolo MG.,2015;90:797-808.European Journal of Medicinal ChemistryImproving selectivity preserving affinity: New piperidine-4-carboxamide derivatives as effective sigma-1-ligands.
5542015Briguglio I, Loddo R, Laurini E, Fermeglia M, Piras S, Corona P, Giunchedi P, Gavini E, Sanna G, Giliberti G, Ibba C, Farci P, La Colla P, Pricl S, Carta A.2015; 105:63-79.European Journal of Medicinal ChemistrySynthesis, citotoxicity and antiviral evaluation of new sereis of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives
5392015Rossi D, Marra A, Rui M, Laurini E, Fermeglia M, Pricl S, Schepmann D, Wuensch B, Peviani M, Curti D, Collina S.,2015,6,138-146.MedChemCommA step forward in the sigma enigma: a role for chirality in the sigma1 receptor–ligand interaction?
5312015Pricl S, Cortelazzi B, Dal Col V, Marson D, Laurini E, Fermeglia M, Licitra L, Pilotti S, Bossi P, Perrone F2015;9(2):389-397.Molecular OncologySmoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
5452015Brambilla L, Genini D, Laurini E, Merulla J, Perez L, Fermeglia M, Carbone GM, Pricl S, Catapano CV2015;9(6):1194-1206.Molecular OncologyHitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
5532015Morgan A, Gandin I, Belcaro C, Palumbo P, Palumbo O, Biamino E, Dal Col V, Laurini E, Pricl S, Bosco P, Carella M, Ferrero GB, Romano C, D'Adamo AP, Faletra F, Vozzi D.2015; 781:32-36.Mutation ResearchTargeting sequencing approach intended to discover new mutations in non.syndromic intellectual disability
5322015Marson D, Laurini E, Poocco P, Fermeglia M, Pricl S2015;7(9):3876-3887.NanoscaleLink to PDF DocumentCationic carbosilane dendrimers and oligonucleotide binding: an energetic affair
5412015Wei T, Chen C, Liu J, Liu C, Posocco P, Liu X, Cheng Q, Huo S, Liang Z, Fermeglia M, Pricl S, Liang X, Rocchi P, Peng L.2015;112(10):2978-2983.Proceedings of the National Academy of Science (PNAS)Link to PDF DocumentAnticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance.
5522015Mehrabadi, FS, Hirsch, O, Zeisig, R, Posocco, P, Laurini E, Pricl, S, Haag, R, Kemmer, W, Calderon. M.2015; 5:78760-78770.RSC AdvancesStructure-activity relationship study of dendriric polyglycerolamines for efficient siRNA transfection
5102014Tintaru A., Chendo C., Wang Q., Viel S., Quéléver G., Peng L., Posocco P., Pricl, S. , Charles L.2014;808:163-74. Analytica Chimica ActaConformational sensitivity of conjugated poly(ethylene oxide)-poly(amidoamine) molecules to cations adducted upon electrospray ionization - A mass spectrometry, ion mobility and molecular modeling study
5282014Liu X, Zhou J, Yu T, Chao Chen C, Cheng Q, Sengupta K, Huang Y, Li H, Cheng Liu C, Yang Wang Y, Posocco P, Wang M, Cui Q, Giorgio S, Fermeglia M, Qu F, Pricl S, Shi Y, Liang Z, Rocchi P, Rossi JJ,Peng L2014;53(44):11822-11827.Angewandte ChemieAdaptive amphiphilic dendrimer based nanoassemblies as robust and versatile siRNA delivery systems
5232014Brune S, Schepmann D, Klempnauer K-H, Marson D, Dal Col V, Laurini E, Fermeglia M, Wünsch B, Pricl S2014;53(18):2993-3003.BiochemistryThe sigma enigma: in silico/in vitro site directed mutagenesis studies unveil σ1 receptor ligand binding.
5192014Zampieri D, Laurini E, Vio L, Golob S, Fermeglia M, Pricl S, Mamolo MG.2014;24(4):1021-5. Bioorganic & Medicinal Chemistry LettersSynthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
5172014Bromfield SM, Posocco P, Chan CW, Calderon M, Guimond SE, Turnbull JE, Pricl S, Smith DK. 2014;5:1484-92.Chemical ScienceNanoscale self-assembled multivalent (SAMul) heparin binders in highly competitive, biologically relevant, aqueous media
5262014Bromfield SM, Posocco P, Fermeglia M, Tolosa J, Herreros-López A, Pricl S, Rodríguez-López J, Smith DK.2014;20(31):9666-74.Chemistry - A European JournalShape-persistent and adaptive multivalency: rigid transgeden (TGD) and flexible PAMAM dendrimers for heparin binding.
5272014Laurini E, Harel D, Marson D, Schepmann D, Schmidt TJ, Pricl S, Wünsch B.2014;83:526-33.European Journal of Medicinal ChemistryIdentification, pharmacological evaluation and binding mode analysis of novel chromene and chromane based σ1 receptor ligands.
5202014Weber F, Brune S, Korpis K, Bednarski PJ, Laurini E, Dal Col V, Pricl S, Schepmann D, Wünsch B.2014;57(7):2884-94.Journal of Medicinal ChemistrySynthesis, Pharmacological Evaluation, and σ1 Receptor Interaction Analysis of Hydroxyethyl Substituted Piperazines.
5212014Kala S, Mak AS, Liu X, Posocco P, Pricl S, Peng L, Wong AS.2014;57(6):2634-42.Journal of Medicinal ChemistryCombination of dendrimer-nanovector-mediated small interfering RNA delivery to target akt with the clinical anticancer drug Paclitaxel for effective and potent anticancer activity in treating ovarian cancer.
5132014Barnard A., Posocco P., Fermeglia M., Tschiche A., Calderon M., Pricl S., Smith D.K.2014;12:446-55. Organic & Biomolecular ChemistryDouble-degradable responsive self-assembled multivalent arrays - temporary nanoscale recognition between dendrons and DNA
5242014Wang Y, Liu X, Laurini E, Posocco P, Ziarelli F, Fermeglia M, Qu F, Pricl S, Zhang C-C-,Peng L 2014;12(26):4723-4729.Organic & Biomolecular ChemistryLink to PDF DocumentMimicking 2-oxoglutaric acid signalling function using molecular probes: insights from structural and functional investigations
5182014Gibbons DL, Pricl S, Posocco P, Laurini E, Fermeglia M, Sun H, Talpaz M, Donato N, Quintás-Cardama A.2014;111(9):3550-5.Proceedings of the National Academy of Science (PNAS)Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy.
4952013Rossi D, Pedrali A, Gaggeri R, Marra A, Pignataro L, Laurini E, Dal Col V, Fermeglia M, Pricl S, Schepmann D, Wünsch B, Peviani M, Curti D, Collina S.2013;21(9):2577-86.Bioorganic & Medicinal ChemistryIdentification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability
4982013Laurini E, Dal Col V, Wunsch B, Pricl S2013;23(10):2868-71.Bioorganic & Medicinal Chemistry LettersAnalysis of the molecular interactions of the potent analgesic S1RA with the σ1 receptor
4942013Amadio M., Pascale A., Govoni S., Laurini E., Pricl S., Gaggeri R., Rossi D., Collina S.2013;81(6):707-14.Chemical Biology & Drug DesignIdentification of peptides with ELAV-like mRNA stabilizing effect: an integrated in vitro/in silico approach
4992013Bromfield SM, Posocco P, Fermeglia M, Pricl S, Rodriguez-Lopez J, Smith DK2013;49(42):4830-2.Chemical CommunicationsLink to PDF DocumentA simple new competition assay for heparin binding in serum applied to multivalent PAMAM dendrimers
5082013Rossi D, Pedrali A, Gaggeri R, Marra A, Pignataro L, Laurini E, Dal Col V, Fermeglia M, Pricl S, Schepmann D, Wünsch B, Peviani M, Curti D, Collina S.2013;8(9):1514-27.ChemMedChemChemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds: promising neuroprotective agents acting as σ1 receptor agonists
5152013Quéléver G., Bouillon C. , Moreno P., Tintaru A., Charles L. , Pricl S., Peng L.2013:167-178. In Dendrimers in Biomedical ApplicationsPoly(Aminoester) dendrimers: design, synthesis and characterization
5162013Liu X., Posocco P., Liu C., Yu T., Wang Q., Dal Col V., Chen C., Wang Y., Rocchi P., Pricl S., Peng L.2013:73-83.In Dendrimers in Biomedical ApplicationsPoly(amidoamine) (Pamam) Dendrimers as non‐viral vectors for the delivery of RNA therapeutics
5032013Brune S, Pricl S, Wünsch B.2013;56(24):9809-19.Journal of Medicinal ChemistryStructure of the σ1 receptor and its ligand binding site
4922013Bromfield SM, Barnard A, Posocco P, Fermeglia M, Pricl S, Smith DK2013;135(8):2911–4.Journal of the American Chemical SocietyLink to PDF DocumentMallard Blue – A High-Affinity Selective Heparin Sensor which Operates in Highly-Competitive Media
5072013Bozzi F, Conca E, laurini E, Posocco P, Lo Sardo A, Jocollè G, Sanfilippo R, Gronchi A, Perrone F, Tamborini E., Pelosi G, Pierotti MA, Maestro R, Pricl S, Pilotti S.2013;93(11):1232-40.Laboratory InvestigationIn vitro and in silico studies of MDM2/MDMX isoforms predict Nutilin-3A sensitivity in well/de-differentiated liposarcomas
4962013Conca E, Miranda C, Dal Col V, Fumagalli E, Pelosi G, Mazzoni M, Fermeglia M, Laurini E, Pierotti MA, Pilotti S, Greco A, Pricl S, Tamborini E.2013;7(4):756-62.Molecular OncologyAre two better than one? A novel double-mutant KIT in GIST that responds to Imatinib
5042013Laurini E, Posocco P, Fermeglia M, Gibbons DL, Quintás-Cardama A, Pricl S.2013;7(5):968-75. Molecular OncologyThrough the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments
5052013Posocco P, Liu X, Laurini E, Marson D, Chen C, Liu C, Fermeglia M, Rocchi P, Pricl S, Peng L.2013;10(8):3262-73. Molecular PharmaceuticsImpact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing
4972013Welsh DJ, Posocco P, Pricl S, Smith DK.2013;11(19):3177-86.Organic & Biomolecular ChemistryLink to PDF DocumentSelf-assembled multivalent RGD-peptide arrays – morphological control and integrin binding
5092013X. Liu, Y. Wang, E. Laurini, P. Posocco, H. Chen, F. Ziarelli, A. Janicki, F. Qu,M. Fermeglia, S.Pricl, C.-C. Zhang. L.Peng 2013,15(18):4662-5. Organic LettersLink to PDF DocumentStructural requirements of 2‑oxoglutaricacid analogues to mimic its signaling function
5122013Ottaviani M.F., Cangiotti M., Fattori A., Coppola C., Posocco P., Laurini E., Liu X., Liu C., Fermeglia M., Peng L., Pricl S.2014;16(2):685-94.Physical Chemistry Chemical PhysicsCopper(ii) binding to flexible triethanolamine-core PAMAM dendrimers: a combined experimental/in silico approach
4742012Gibbons DL, Pricl S, Kantarjian H, Cortes J, Quintás-Cardama A.2012;118:293-9.CancerLink to PDF DocumentThe rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm
4842012Posocco P, Laurini E, Col VD, Marson D, Karatasos K, Fermeglia M, Pricl S.2012;19:5062-87.Current Medicinal ChemistryLink to PDF DocumentTell Me Something I Do Not Know. Multiscale Molecular Modeling of Dendrimer/Dendron Organization and Self-Assembly In Gene Therapy.
4782012Meyer C, Schepmann D, Yanagisawa S, Yamaguchi J, Dal Col V, Laurini E, Itami K, Pricl S, Wünsch B2012;55(18):8047–65.Journal of Medicinal ChemistryPd-catalyzed direct C-H bond functionalization of spirocyclic sigma-1 ligands: generation of a pharmacophore model and analysis of reverse binding mode by docking into a 3D homology model of the sigma-1 receptor.
4692012Karatasos K, Posocco P, Laurini E, Pricl S.2012, 12(2):225-40.Macromolecular BiosciencePoly(amidoamine)-based Dendrimer/siRNA Complexation Studied by Computer Simulations: Effects of pH and Generation on Dendrimer Structure and siRNA Binding.
4872012Laurini E, Marson D, Dal Col V, Fermeglia M, Mamolo MG, Zampieri D, Vio L, Pricl S.2012;9(11):3107-26.Molecular PharmaceuticsAnother brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands
4682012Liu X, Liu C, Laurini E, Posocco P, Pricl S, Qu F, Rocchi P, Peng L.2012;9(3):470-81.Molecular PharmaceuticsLink to PDF DocumentEfficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer
4762011Erik Laurini, Valentina Dal Col, Maria Grazia Mamolo, Daniele Zampieri, Paola Posocco, Maurizio Fermeglia, Luciano Vio, Sabrina Pricl2011;2:834-839.ACS Medicinal Chemistry LettersLink to PDF DocumentHomology Model and Docking-Based Virtual Screening for Ligands of the sigma 1 Receptor.
4732011Liu X, Wu J, Yammine M, Zhou J, Posocco P, Viel S, Liu C, Ziarelli F, Fermeglia M, Pricl S, Victorero G, Nguyen C, Erbacher P, Behr JP, Peng L.22:2461-73 (2011)Bioconjugate ChemistryLink to PDF DocumentStructurally flexible triethanolamine core PAMAM dendrimers are effective nanovectors for DNA transfection in vitro and in vivo to the mouse thymus
4432011Dileo P., Pricl S., Tamborini E., Negri T., Stacchiotti S., Gronchi A., Posocco P., Laurini E., Coco P., Fumagalli E., Casali P.G., Pilotti S.128:983-90 (2011)International Journal of CancerLink to PDF DocumentImatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: An imaging, biochemical and molecular modeling study
4712011Barnard A, Posocco P, Pricl S, Calderon M, Haag R, Hwang ME, Shum VW, Pack DW, Smith DK.2011;133:20288-300.Journal of the American Chemical SocietyLink to PDF DocumentDegradable self-assembling dendrons for gene delivery: experimental and theoretical insights into the barriers to cellular uptake.
4572011Jones S..P, Gabrielson N.P., Wong C.H., Chow H.F., Pack D.W., Posocco P., Fermeglia M., Pricl S., Smith D.K.8:416-29 (2011)Molecular PharmaceuticsLink to PDF DocumentHydrophobically Modified Dendrons: Developing Structure-Activity Relationships for DNA Binding and Gene Transfection
4582011Pierotti M., Tamborini E., Negri T., Pricl S., Pilotti S.2011;8:161-170.Nature Reviews Clinical OncologyLink to PDF DocumentTargeted therapy in GIST: in silico modeling for prediction of resistance
4752011Liu X, Chen H, Laurini E, Wang Y, Dal Col V, Posocco P, Ziarelli F, Fermeglia M, Zhang CC, Pricl S, Peng L.2011;13:2924-7.Organic LettersLink to PDF Document2-difluoromethylene-4-methylenepentanoic acid, a paradoxical probe able to mimic the signaling role of 2-oxoglutaric acid in cyanobacteria.
4532010Pricl SConference CDACS - American Chemical Society, Boston, USIs variety the spice of life?
4542010Pricl S., Posocco P., Fermeglia M., Karatasos K., Peng L., Smith D.K.Conference CDAIChE Annual Meeting 2010, American Institute of Chemical Engineering, Salt Lake City, USThe Sound of Silence. Multiscale Molecular Simulations and Experiments in Developing Nanocarrier/Nucleic Acid Systems
4362010Tonelli M., Boido V., La Colla P., Loddo R., Posocco P., Paneni M.S., Fermeglia M., Pricl S.18:2304-2316 (2010)Bioorganic & Medicinal ChemistryLink to PDF DocumentPharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV)
4422010Tonelli M., Simone M., Tasso B., Novelli F., Boido V., Sparatore F., Paglietti G., Pricl S., Giliberti G., Blois S., Ibba C., Sanna G., Loddo R., La Colla P.18:2937-2953 (2010)Bioorganic & Medicinal ChemistryLink to PDF DocumentAntiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives
4482010Giliberti G., Ibba C., Marongiu E., Loddo R., Tonelli M., Boido V., Laurini E., Posocco P., Fermeglia M., Pricl S.18:6055-6068 (2010)Bioorganic & Medicinal ChemistryLink to PDF DocumentSynergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase
4392010Laurini E., Zampieri D., Mamolo M.G., Vio L., Zanette C., Florio C., Posocco P., Fermeglia M., Pricl S.20:2954-2957 (2010)Bioorganic & Medicinal Chemistry LettersLink to PDF DocumentA 3D-Pharmacophore Model for sigma-2 Receptors Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives
4462010S. Pricl,D. L. Gibbons,P. Posocco,E. Laurini,M. Fermeglia,H. M. Kantarjian,M. Talpaz,J. Cortes,M. Young,H. Sun,L. F. Peterson,N. Donato,A. Quintas-Cardama116-21:1392-1393 (2010)BloodThe Novel BCR-ABL1 V304D Mutation Induces Pan-Tyrosine Kinase Inhibitor Resistance by a Unique Kinase Lateral Escape Mechanism and Is Associated with Very Poor Prognosis In Patients (PTS) with Chronic Myeloid Leukemia (CML)
4452010Posocco P., Pricl S., Jones S., Barnard A., Smith D.K.1:393-404 (2010)Chemical ScienceLink to PDF DocumentLess is more: multiscale modelling of self-assembling multivalency and its impact on DNA binding and gene delivery
4402010Pavan G.M., Posocco P., Tagliabue A., Maly M., Malek A., Danani A., Ragg E., Catapano C.V., Pricl S.16:7781-7795 (2010)Chemistry - A European JournalLink to PDF DocumentPAMAM Dendrimers for siRNA Delivery: Computational and Experimental Insights
4412010Jones S.P., Pavan G.M., Danani A., Pricl S., Smith D.K.16:4519-4532 (2010)Chemistry - A European JournalLink to PDF DocumentQuantifying the Effect of Surface Ligands on Dendron-DNA Interactions: Insights into Multivalency through a Combined Experimental and Theoretical Approach
4442010Posocco P., Fermeglia M., Pricl S.20:7742-7753 (2010)Journal of Materials ChemistryLink to PDF DocumentMorphology prediction of block copolymers for drug delivery by mesoscale simulations
4352010Pierotti M.A., Negri T., Tamborini E., Perrone F., Pricl S., Pilotti S.4:19-37 (2010)Molecular OncologyLink to PDF DocumentTargeted Therapies: The Rare Cancer Paradigm
4562010Pricl S., Posocco P., Laurini E., Fermeglia M., Karatasos K., Peng L., Smith D.K.Conference CD and WebNanotechItaly, Convegno Italiano di Nanotecnologie, Venezia, IWhen virtual and real meet: computational/experimental evidences for designing efficient nanovectors for siRNA/DNA delivery
3992009Zampieri D., Mamolo M.G., Laurini E., Fermeglia M., Posocco P., Pricl S., Banfi E., Scialino G., Vio, L.17:4693-4707(2009)Bioorganic & Medicinal ChemistryLink to PDF DocumentAntimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations.
4002009Tonelli M., Vazzana I., Tasso B., Boido V., Sparatore F., Fermeglia M., Paneni M.S., Posocco P., Pricl S., La Colla P., Ibba C., Secci B., Collu G., Loddo, R.17:4425-4440(2009)Bioorganic & Medicinal ChemistryLink to PDF DocumentAntiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives.
4372009Carta A., Pricl S., Piras S., Fermeglia M., La Colla,P., Loddo R.44:5117-5122 (2009)European Journal of Medicinal ChemistryLink to PDF DocumentActivity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants
4202009Posocco P., Fermeglia M., Pricl S.FOMMS2009, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USAMulholland Dr. Multiscale molecular modeling of the self-assembly of di/triblock copolymers for drug delivery
4212009Pricl S., Posocco P., Pavan G.M., Fermeglia M., Scocchi G., Malek A., Maly M., Danani A., Catapano C., Peng L., Smith D.K.FOMMS2009, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USAThe sound of silence. Experimental/computational investigations of dendrimer-based sirna/dna delivery systems
4242009Zampieri D., Mamolo M., Laurini E., Florio C., Zanette C., Fermeglia M., Posocco P., Paneni M.S., Pricl S., Vio, L. 52: 5380-5393 (2009)Journal of Medicinal ChemistryLink to PDF DocumentSynthesis, Biological Evaluation and Three-Dimensional in Silico Pharmacophore Model for σ1 Receptor Ligands Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives
3662009Negri T., Pavan G.M., Virdis E., Greco A., Fermeglia M., Pricl S., Pierotti M.A., Pilotti S., Tamborini E.101: 194-204 (2009)Journal of National Cancer InstituteLink to PDF DocumentT670X KIT mutations in gastrointestinal stromal tumors: making sense of missense.
4022009Pavan G.M., Danani A., Pricl S., Smith, D.K.131:9686-9694(2009)Journal of the American Chemical SocietyLink to PDF DocumentModeling the multivalent recognition between dendritic molecules and DNA: Understanding how ligand "sacrifice" and screening can enhance binding.
4382009Conca E., Negri T., Gronchi A., Fumagalli E., Tamborini E., Pavan G.M., Fermeglia M., Pierotti M. A., Pricl S., Pilotti S.8:2491-2495 (2009)Molecular Cancer TherapeuticsActivate and resist: L576P-KIT in GIST
3942008Posocco P., Pavan G., Scocchi G., Handgraaf J.W., Malek A., Maly M., Fermeglia M., Fraaije J., Catapano V., Danani A., Pricl S.57: 154-159 (2008)Advances in Science and TechnologyLink to PDF DocumentBase Invaders. Coupling Experiments and Multiscale Modeling of Dendrimer-Based siRNA Delivery Agents
3682008Mazzei M., Nieddu E., Mielea M., Balbia, A., Ferrone M., Fermeglia M., Mazzei M.T., Pricl S., LaColla P., Marongiu F., Ibba C., Loddo R.16:2591-2605 (2008)Bioorganic & Medicinal ChemistryLink to PDF DocumentActivity of Mannich bases of 7-hydroxycoumarin against Flaviviridae
3872008Tonelli M., Boido V., Canu C., Sparatore A., Sparatore F., Paneni M.S., Fermeglia M., Pricl S., La Colla P., Casula L., Ibba C., Collu D., Loddo R.16: 8446-8465 (2008)Bioorganic & Medicinal ChemistryLink to PDF DocumentAntimicrobial and cytotoxic arylazoenamines. Part III: Antiviral activity of selected classes of arylazoenamines.
4262008Angusti A., Manfredini S., Durini E., Ciliberti N., Vertuani S., Solaroli N., Pricl S., Ferrone M., Fermeglia M., Loddo R., Secci B., Visioli A., Sanna T., Collu G., Pezzullo M., La Colla P.56: 423-432 (2008)Chemical and Pharmaceutical BulletinDesign, synthesis and anti flaviviridae activity of N6-, -O- and 5 O-substituted adenine nucleoside analogs
3942008Posocco P., Pavan G., Scocchi G., Handgraaf J.W., Malek A., Maly M., Fermeglia M., Fraaije J., Catapano V., Danani A., Pricl S.57: 154-159 (2008)CIMTEC 2008, 3rd International Conference on SMART MATERIALS, STRUCTURES AND SYSTEMS, Acireale, ItalyLink to PDF DocumentBase Invaders. Coupling Experiments and Multiscale Modeling of Dendrimer-Based siRNA Delivery Agents
3882008Fermeglia M., Pricl S.1: 61 (2008)Drug Design and Discovery for Developing Countries, ICS-UNIDO. Trieste, IMultiscale molecular strategies for drug delivery
4192008Fermeglia M., Pricl S.CD (2008)Drug Design and Discovery for Developing Countries, ICS-UNIDO. Trieste, IMultiscale Molecular Strategies for Drug Delivery
4012008Carta A., Piras S., Paglietti G., Pricl S., La Colla, P., Busonera B., Loddo, R.4:194-205(2008)Medicinal Chemistry2(3)-Aryl-thio(oxy)-methylquinoxaline derivatives: A new class of P-glycoprotein-mediated drug efflux inhibitors.
4032008McAuliffe J.C., Wang W.-L., Pavan G.M., Pricl S., Yang D., Chen S.S., Lazar A.J.F., Pollock R.E., Trent J.C.2:161-163(2008)Molecular OncologyUnlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors.
4152008Paneni M.S., Posocco P., De Santo I., Causa F., Netti P.A., Pricl S.NNC: National nanomedicne Conference, Genova, 28-29 February 2008Nanochannels versus macromolecules:a multiscale computational approch of macromolecular transport in confined nanospaces
3652008Pricl S., Pavan G.M., Negri T., Fermeglia M., Pierotti M.A., Pilotti S., Tamborini E.xx:xx-xx (2008)OncogeneThe long and winding road of the KIT juxtamembrane (JXM) domain
3532007Posocco P., Scocchi G., Fermeglia M., Pricl S., Ferrari M.1:113 (2007)11th International Conference on Properties and Phase Equilibria for Product and Process Design PPEPPD, Crete, Greece, 2007The nanoroad less travelled. A multiscale approach to self-assembly of dendrimers for cancer therapy
3372007Carta A., Loriga M., Paglietti G., Ferrone M., Fermeglia M., Pricl S., Sanna T., Ibba C., La Colla P., Loddo R.15: 1914-1927 (2007)Bioorganic & Medicinal ChemistryLink to PDF DocumentDesign, synthesis and preliminary in vitro and in silico antiviral activity of [4,7]phenantrolines and 1-oxo-1,4-dihydro-[4,7]phenantrolines against a single-stranded positive sense RNA genome viruses
3702007Zampieri D., Mamolo M.G., Vio L., Banfi E., Scialino G., Fermeglia M., Ferrone M., Pricl S.15:7444-7458 (2007)Bioorganic & Medicinal ChemistryLink to PDF DocumentSynthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method.
3492007Posocco P., Ferrone M., Fermeglia M., Pricl S.40: 2257-2266 (2007)MacromoleculesLink to PDF DocumentBinding at the core. Computational study of structural and ligand binding properties of naphthiridine based dendrimers
3542007Posocco P., Paneni M.S., Pricl Sx: xx-xx (2007)XVI International HIV DRUG RESISTANCE Workshop, Hilton Barbados, Barbados, 2007Non-Nucleoside RT Inhibitors (NNRTIs) research: Breaking Down Resistance Using Advanced Computational Procedures
3052006Pricl S., Ferrone M., Cosoli P., Paneni M.S., Fermeglia M., Cosentino C., Amato F., Cheng M.C.C., Ferrari M.53: 79-84 (2006)11th International Conferences on Modern Materials and Technologies CIMTEC, Acireale, IT, 2006Link to PDF DocumentRelease of Proteins from Nanochannel Delivery Systems: a Coupled Many-Scale Simulation - Experimental Investigation
3352006Pricl S., Fermeglia M., Tamborini E., Pierotti M.A., Pilotti S.1: 68 (2006)18th EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics", Prague, Cz,Link to PDF DocumentEquilibrium on hold. A computational rationale for the role of kit juxtamembrane mutations in controlling receptor autophosphorylation
3472006Pricl S., Ferrone M., Paneni M.S., Cosoli P., Fermeglia M., Perrone F., Da Riva L., Tamborini E., Suardi S., Pierotti M.P., Pilotti S.CD 1: 1556 (2006)97th AACR Annual Meeting, Washington, DC, US, 2006Link to PDF DocumentAngels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer
3052006Pricl S., Ferrone M., Cosoli P., Paneni M.S., Fermeglia M., Cosentino C., Amato F., Cheng M.C.C., Ferrari M.53: 79-84 (2006)Advances in Science and TechnologyLink to PDF DocumentRelease of Proteins from Nanochannel Delivery Systems: a Coupled Many-Scale Simulation - Experimental Investigation
3132006Toth R., Ferrone M., Miertus S., Chiellini E., Fermeglia M., Pricl S.7: 1714-1719 (2006)BiomacromoleculesLink to PDF DocumentStructure and energetics of biocompatible polymer nanocomposite sistems: a molecular dynamics study
3182006Pricl S., Ferrone M., Fermeglia M., Amato F., Cosentino C., Cheng M.M.C., Walczak R., Ferrari M.8: 277-290 (2006)Biomedical MicrodevicesLink to PDF DocumentMultiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations
3192006Pricl S., Ferrone M., Fermeglia M., Amato F., Cosentino C., Cheng M.M.C., Walczak R., Ferrari M.8: 291-298 (2006)Biomedical MicrodevicesLink to PDF DocumentMultiscale modeling of protein transport in silicon membrane nanochannels. Part 2. From molecular parameters to a predictive continuum diffusion model
3292006Pricl S., Salvatori G., Shehata N.1: 71 (2006)Ceramic, Cell and Tissue 10th Annual Seminar & Meeting - materials for scaffolding of biologically engineered systems, Faenza, ItalyWhich kinds of drugs? Which kind of actions?
3302006Fermeglia M., Ferrone M., Cosoli P., Paneni M.S., Cosentino C., Amato F., Cheng M.M.C., Walczak R., Pricl S., Ferrari M.CD 1: 43 (2006)FOMMS2006, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USALink to PDF DocumentDelivered to Perfection at Nanoscale. A Coupled Multiscale Simulation/Experimental Investigation of Protein Release from Nanochannel Delivery Systems
3462006Ferrone M., Fermeglia M., Paneni M.S., Pierotti M.A., Pilotti S., Tamborini E. , Pricl S.CD 1: 41 (2006)FOMMS2006, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USALink to PDF DocumentOf life and Death: Chronic Myeloid Leukemia and the Bcr-Abl/Imatinib Paradigm
3502006Pricl S., Ferrone M., Posocco P., Pavan G.M., Fermeglia M., La Colla P., Loddo R.1: 62-63 (2006)HIV DART 2006: Frontiers in drug development for antiretroviral therapies, Cancun, Mexico, 2006Link to PDF DocumentA new twist for an old song. The DABO story revisited
3512006Pricl S., Ferrone M., Posocco P., Fermeglia M., Sanna G., Collu G., La Colla P., Loddo R., Sias A., Piras S., Carta A.1: 63 (2006)HIV DART 2006: Frontiers in drug development for antiretroviral therapies, Cancun, Mexico, 2006Link to PDF DocumentChasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants
3122006Scialino G., Banfi E., Zampieri D., Mamolo M., Vio L., Ferrone M., Fermeglia M., Paneni M.S., Pricl S.58: 76-84 (2006)Journal of Antimicrobial ChemoterapyLink to PDF DocumentAntifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined and computational approach
3392006Pricl S., Tamborini E., Pierotti M., Pilotti S.98: 1583-1584 (2006)Journal of National Cancer InstituteLink to PDF DocumentLetter to the editor: Response of a KIT-Positive Extra-abdominal Fibromatosis to Imatinib Mesylate and KIT Genetic Analysis
3402006Carta A., Loriga G., Pirasa S., Paglietti G., La Colla P., Collu G., Piano M.A., Loddo R., Ferrone M., Fermeglia M., Pricl S.2: 577-589 (2006)Medicinal ChemistryLink to PDF DocumentSynthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides
3112006Ferrone M., Perrone F., Tamborini E., Paneni M.S., Fermeglia M., Suardi S., Pastore E., Delia D., Pierotti M.A., Pricl S., Pilotti S.5(6):1467-73 (2006)Molecular Cancer TherapeuticsLink to PDF DocumentFunctional analysis and molecular modelling show a preserved wild type activity of p53 C238Y
3002006Tamborini E., Pricl S., Negri T., Lagonigro M.S., Miselli F., Greco A., Gronchi A., Casali P., Ferrone M., Fermeglia M., Pierotti M.A., Pilotti S.25: 6140-6146 (2006)OncogeneLink to PDF DocumentFunctional analyses and Molecular modeling of two c-Kit mutations responsible for Imatinib secondary resistance in GIST patients
3362006Pricl S., Fermeglia M., Tamborini E., Pierotti M.A., Pilotti S.1: 47 (2006)Targeted therapies in cancer: myth or realty? Milan, ItalyLink to PDF DocumentActivity of PKC412 against an Imatinib-resistant gastrointestinal stromal tumor (GIST) carrying a D842V mutation in PDGFR: a combined clinical/modeling study
3072005Toth R., Ferrone M., Miertus S., Chiellini E., Fermeglia M., Pricl S.1: 217 (2005)29th International Conference on Solution Chemistry, Portoroz, Slovenija, 2005Link to PDF DocumentSimulation insight on the structure and energetics of biocompatible polymer nanocomposite systems
2982005Pricl S:, Tamborini E., Ferrone M., Paneni M.S., Fermeglia M., Pierotti M.A., Pilotti S.Proceedings Supplement 1: 30-31 (2005)AACR Annual Meeting, Anaheim, CA, US, 2005Link to PDF DocumentCan computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm
2992005Tamborini E., Pricl S., Negri T., Lagonigro M.S., Gabanti E., Greco A., Dagrada G., Miselli F., Ferrone M., Pierotti M.A., Pilotti S.Proceedings Supplement 1: 147-148 (2005)AACR Annual Meeting, Anaheim, CA, US, 2005Link to PDF DocumentBiochemical analyses and molecular modelling of two aminoacidic substitutions detected in two gastrointestinal stromal tumor (GIST) patients showing acquired resistance to imatininb
2932005Pricl S., Ferrone M., Paneni M.S., Fermeglia M.,Tamborini E., Negri T., Lagonigro M.S., Miselli F., Greco A., Pierotti M.A., Pilotti S.11: 9032s (2005)AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications, Philadelphia, PA, USALink to PDF DocumentT670X kit mutations in gastrointestinal stromal tumors: making sense of missense
2942005Pricl S., Ferrone M., Paneni M.S., Cosoli P., Fermeglia M., Pierotti M.A., Pilotti S., Tamborini E.CD 2: 393a (2005)AIChE Annual Meeting 2005, Cincinnati, OH, USALink to PDF DocumentChanges and challenges: gist, mutated c-kit and imatinib resistance
2952005Paneni M.S., Ferrone M., Cosoli P., Fermeglia M., Pricl M.CD 2: 393b (2005)AIChE Annual Meeting 2005, Cincinnati, OH, USALink to PDF DocumentWhere are we in hiv research? a novel, computer-based strategy predicting resistance to HIV-1 NNRTIs
2962005Toth R., Ferrone M., Miertus S:, Chiellini E., Fermeglia M., Pricl S.CD 2: 414g (2005)AIChE Annual Meeting 2005, Cincinnati, OH, USALink to PDF DocumentNano-scaled inorganic/biopolymer composites: molecular modeling vistas
2862005Mamolo M.G., Zampieri D., Vio L., Fermeglia M., Ferrone M., Pricl S., Scialino G., Banfi E.13: 3797-3809 (2005)Bioorganic & Medicinal ChemistryLink to PDF DocumentAntimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations
2822005Tamborini E., Gabanti E., Lagonigro M.S., Negri T., Pricl S., Pierotti M.A., Pilotti S.65: 1115 (2005)Cancer ResearchLink to PDF DocumentKIT/Val654Ala receptor detected in one imatinib-resistant GIST patient.
2932005Pricl S., Ferrone M., Paneni M.S., Fermeglia M.,Tamborini E., Negri T., Lagonigro M.S., Miselli F., Greco A., Pierotti M.A., Pilotti S.11: 9032s (2005)Clinical Cancer ResearchLink to PDF DocumentT670X kit mutations in gastrointestinal stromal tumors: making sense of missense
2902005Ferrone M., Fermeglia M., Pricl S., Cosentino C., Amato F., Ferrari M.1: 63 (2005)Euronanoforum 2005 - Nanotechnology and the Health of the EU Citizen in 2020, Edimburgh, UKLink to PDF DocumentDiffusion of proteins in nanochannels. A many-scale simulation approach
2912005Ferrone M., Paneni M.S., Cosoli P., Fermeglia M., Tamborini E., Pierotti M.A., Pilotti S., Pricl S.1:64 (2005)Euronanoforum 2005 - Nanotechnology and the Health of the EU Citizen in 2020, Edimburgh, UKLink to PDF DocumentFighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm
2922005Cosoli P., Ferrone M., Paneni M.S., Fermeglia M., Pricl S.1:90 (2005)Euronanoforum 2005 - Nanotechnology and the Health of the EU Citizen in 2020, Edimburgh, UKLink to PDF DocumentTake a walk on the nano side: structural and energetical analysis of ATP-binding pocket mutations of the cardiac beta-myosin heavy chain implicated in familial hypertrophic cardiomyopathy
3032005Ferrone M., Pricl S., Fermeglia M., Paneni M.S., Angusti A., Ciliberti N., Buzzoni L., Durini E., Vertuani S., Manfredini S., Loddo R., La Colla P.1: 32-33 (2005)Global Antiviral JournalLink to PDF DocumentThree-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase
3042005Pricl S., Fermeglia M., Ferrone M., Paneni M.S., Cosoli P., Costi R., Roux A., Artico M., Di Santo R.1: 36-37 (2005)Global Antiviral JournalLink to PDF DocumentNovel Aryl Diketo Acids (ADKs) as Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA-Polymerase: Better Understanding Through Molecular Modeling
3222005Angusti A., Auzzas L., Boido V., Canu C., Carta A., Ciliberti N., Ferrone M., Loddo R., La Colla P., Loriga M., Manfredini S., Mazzei M., Nieddu E., Paglietti G., Paneni M.S., Pricl S., Rassu G., Sparatore F., Tasso B., Vitale G.1: 37-38 (2005)Global Antiviral JournalLink to PDF DocumentNon-nucleoside anti-Flaviviridae agents from different molecular classes: a jointed experimental/modeling effort
2572005Manfredini S., Angusti A., Ciliberti N., Durini E., Vertuani S., Buzzoni L., Coslanich A., Fermeglia M., Ferrone M., Paneni M.S., Pricl S., La Colla P., Sanna G., Cadeddu A., Mura M., Loddo R.[ISBN: 978-0-9754188-1-9]: 279-318 (2005)In "Framing the knowledge of viral hepatitis", edited by Rymond F. Schinasi, IHL Press, Arlington MA, US (2005)Hindered nucleoside analogs as hinibitors of HCV RNA-dependent RNA-polymerase: evolving vistas
2882005Di Santo R., Fermeglia M., Ferrone M., Paneni M.S., Costi R., Artico M., Roux A., Gabriele M., Tardiff K.D., Siddiqui A., Pricl S.48:6304-6314 (2005)Journal of Medicinal ChemistryLink to PDF DocumentA simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors
2872005Fermeglia M., Ferrone M., Tamborini E., Pricl S.4: 1167-1174 (2005)Molecular Cancer TherapeuticsLink to PDF DocumentTT315I mutated bcr-abl in chronic myeloid leukemia and imatinib: insights from a computational study
3012005Zampieria D., Mamolo M.G., Vio L., Tonzara E., Pricl S., Ferrone M., Scialino G., Banfi E.1: P68 (2005)Second Joint Italian-Swiss Meeting on Medicinal Chemistry, Modena, IT, 2005Link to PDF DocumentSynthesis, antifungal and antimycobacterial activities of new bisimidazole derivatives
3022005Carta A., Loriga M., Paglietti G., Ferrone M., Pricl S., Piano M.A., Meloni M. La Colla P.1:P42 (2005)Second Joint Italian-Swiss Meeting on Medicinal Chemistry, Modena, IT, 2005Link to PDF DocumentSynthesis and antiviral activity of 4,7-Phenantroline derivatives against RNA Viruses
3032005Ferrone M., Pricl S., Fermeglia M., Paneni M.S., Angusti A., Ciliberti N., Buzzoni L., Durini E., Vertuani S., Manfredini S., Loddo R., La Colla P.1: 32-33 (2005)The 6th biennial meeting in this HEP DART series, HEP DART 2005 Frontiers in Drug Development for Viral Hepatitis, Big Island, Hawaii, US, 2005Link to PDF DocumentThree-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase
3042005Pricl S., Fermeglia M., Ferrone M., Paneni M.S., Cosoli P., Costi R., Roux A., Artico M., Di Santo R.1: 36-37 (2005)The 6th biennial meeting in this HEP DART series, HEP DART 2005 Frontiers in Drug Development for Viral Hepatitis, Big Island, Hawaii, US, 2005Link to PDF DocumentNovel Aryl Diketo Acids (ADKs) as Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA-Polymerase: Better Understanding Through Molecular Modeling
3222005Angusti A., Auzzas L., Boido V., Canu C., Carta A., Ciliberti N., Ferrone M., Loddo R., La Colla P., Loriga M., Manfredini S., Mazzei M., Nieddu E., Paglietti G., Paneni M.S., Pricl S., Rassu G., Sparatore F., Tasso B., Vitale G.1: 37-38 (2005)The 6th biennial meeting in this HEP DART series, HEP DART 2005 Frontiers in Drug Development for Viral Hepatitis, Big Island, Hawaii, US, 2005Link to PDF DocumentNon-nucleoside anti-Flaviviridae agents from different molecular classes: a jointed experimental/modeling effort
2802004Pricl S., Coslanich A., Fermeglia M., Ferro M., Ferrone M., Paneni M.S., Tamborini E., Negri T., Lagonigro S., Greco A., Gabanti E., Pierotti M.A., Pilotti S.1: 187 (2004)16th EORTC-NCI-AARC Symposium on "Molecular Targets and Cancer Therapeutics", Geneve, Switzerland, 2004Link to PDF DocumentAnalogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach
2722004Pricl S., Fermeglia M., Ferrone M., Coslanich A., Paneni M.S, Tambori E., Pilotti S.1:67g (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF DocumentA new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: a coupled experimental and modeling investigation
2762004Paneni M.S., Ferrone M., Coslanich A:, Fermeglia M., Pricl S., Miertus S., Frecer V., Carniel E., Mestroni L.1:448b (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF DocumentA talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding
2772004Pricl S., Fermeglia M., Ferrone M., Coslanich A., Paneni M.S., Manfredini S., Angusti A., La Colla P., Mura M.1:448a (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF Document"Fatty" nucleoside analogs as HCV NS5b inhibitors
2782004Pricl S., Fermeglia M., Coslanich A., Ferrone M., Paneni M.S., Caliceti P., Salmaso S., Semenzato S.1: 494b (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF DocumentDesign, synthesis and characterization of folate-cyclodextrin bioconjugate for active drug delivery: results from combined computational and experimental efforts
2352004Mamolo M.G., Zampieri D., Falagiani V., Vio L., Fermeglia M., Ferrone M., Pricl S., Banfi E., Scialino G.5:231-250 (2004)ArkivocLink to PDF DocumentAntifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives
2592004Metullio L., Ferrone M., Coslanich A., Fuchs S., Fermeglia M., Paneni M.S., Pricl S.5:1371-1378 (2004)BiomacromoleculesLink to PDF DocumentPolyamidoamine (yet not PAMAM) Dendrimers as Bioinspired Materials for Drug Delivery: Structure-Activity Relationships by Molecular Simulations
2612004Pricl S., Ferrone M., Paneni M.S., Angusti A., Manfredini S., La Colla P., Mura M.1: 115-118 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentDesign, synthesis and activity of hindered nucleoside analogs with anti-Flaviviridae activity, and their interaction with RdRp
2622004Pricl S., Ferrone M., Paneni M.S., Tamborini E., Pilotti S., Pierotti M.A.1: 145-148 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentIs tailor-fitting always the best choice? The case of mutations in GISTs and Imatinib
2632004Paneni M.S., Ferrone M., Pricl S., Carniel E., Miertus S., Frecer V., Mestroni L.1: 253-256 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentGenotype-phenotype correlations of myosin mutations: a molecular simulation study
2642004Ferrone M., Pricl S., Paneni M.S., Tamborini E., Pilotti S., Pierotti M.A.1: 273-276 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentP53 mutations in sporadic and NF1 related malignant peripheral nerve sheath tumors (MPNST): from clinical evidences to a molecular rationale
2662004Pricl S.2: 1191-1194Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentFree energy calculations in biological systems
2832004Pricl S., Coslanich A., Fermeglia M., Ferrone M., Paneni M.S., Loddo R., Cabizza A., Sanna G., Murreddu M., La Colla P.1:41-42 (2004)HIV Dart 2004, Montego Bay, Jamaica 2004Link to PDF DocumentPrediction fo HIV-1 resistance to NNRITs: a computer-aided molecular-based rationale
1862004Frecer, V., Kabelac, M., De Nardi, P., Pricl, S., Miertus, S.22: 209-220 (2004)Journal of Molecular Graphics and ModellingLink to PDF DocumentStructure-based design of inhibitors of NS3 serine protease of hepatitis C virus
2812004Manfredini S., Angusti A., Veronese A.C, Durini E., Vertuani S., Nalin F., Solaroli N., Ferrone M., Pricl S., Mura M., Piano M.A, Poddesu B., Cadeddu A., La Colla P., Loddo R.76:1007-1015 (2004)Pure and Applied ChemistryLink to PDF DocumentHindered Nucleoside Analogs (HNA) as Antiflaviviridae Agents
3152004Banfi E., Ferrone M., Mamolo M., Pricl S., Scialino G., Vio L., Zampieri D.Third Croatian Congress of Microbiology with International Participation, Porec, Croatia, 2004Molecular modeling in drug design: new chemicals with antitubercolar, antifungal, antibacterial activity: synthesis and MIC evaluation; experimental and computational approach
3162004Zampieri D., Mamolo M., Vio L., Ferrone M., Pricl S., Scialino G., Banfi E.1: 047 (2004)Wolrd Conference on Magic Bullets Celebrating Paul Ehrlich's 150th Birthday, Nurnberg, Germany, 2004Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach
2242003Pricl S., Ferrone M., Fermeglia M., Tamborini E., Delia D., Pierotti M.A., Pilotti S.CD 1: MEDI 74 (2003)225th ACS National Meeting, New Orleans, Usa, 2003Link to PDF DocumentC-kit mutants in GISTs and their interaction with STI 571: insights from computer simulations and clinical trials
2252003Pricl S., Ferrone M., Fermeglia M., Laurent L., Tamborini E., Delia D., Pierotti M.A., Pilotti S.CD 1: MEDI 140 (2003)225th ACS National Meeting, New Orleans, Usa, 2003Link to PDF DocumentCompuational alanine scanning to probe DNA-wild typeand mutant P53 interactions
2262003Pricl S., Ferrone M., Fermeglia M., Lodi A.CD 1: CARB 69 (2003)225th ACS National Meeting, New Orleans, Usa, 2003Link to PDF DocumentMolecular dynamics and free energy analyses of the interactions between b-cyclodextrin and some anticancer drugs
2282003Ferrone M., Coslanich A., Fermeglia M., Felluga F., Pitacco G., Valentin E., Pricl S.1: 55 (2003)5° Convegno FISV, Rimini, I, 2003Link to PDF DocumentEnantioselectivity of alpha-chytripsyn towards 4,5-disubstituted-gamma-lactams: a new perspective from molecular simulations
2402003Pricl S., Coslanich A., Fermeglia M., Ferrone M., Albertini V., Bonadiman L., Tamborini E., Pierotti M.A., Pilotti S.1: 107g (2003)AIChE Annual Meeting 2003, S. Francisco, USALink to PDF DocumentA Tumor (GIST), a Mutated Gene (c-kit), and a Molecular Inhibitor (Imatinib): Insights from Computer Simulations
2412003Pricl S., Coslanich A., Fermeglia M., Ferrone M., Metullio L., Fuchs S.1: 472b (2003)AIChE Annual Meeting 2003, S. Francisco, USALink to PDF DocumentTowards Dendrimers as Anticancer Drug Carriers: from in Silico to in Vivo Characterization
1912003Manfredini S., Solaroli N., Porcu L., Durini E., Angusti A., Vertuani S., Verri A., Spadai S., Focher F., Ferrone M., Pricl, S., De Clercq E., Balzarini J.14: 183-194 (2003)Antiviral Chemistry & ChemotherapyLink to PDF DocumentDesign, Synthesis and Activity of Phosphonoacetic Acid (Ppa) Ester and Amide Bioisosters of Ribofuranosylnucleoside Diphosphates as Potential Ribonucleotide Reductase Inhibitors.
2342003Caliceti P., Salmaso S., Carofiglio T., Fornasier R., Fermeglia M., Ferrone M., Pricl S.14: 899-908 (2003)Bioconjugate ChemistryLink to PDF DocumentSynthesis and physico-chemical characterization of folate-cyclodextrin bioconjugate for active drug delivery
1852003Fermeglia M., Ferrone M., Lodi A., Pricl S.53: 15-44 (2003)Carbohydrate PolymersLink to PDF DocumentHost-guest inclusion complexes between anticancer drugs and beta-cytclodextrin: computational studies.
2442003Coslanich A., Fermeglia M., Ferrone M., Paneni M.S., Pricl S., Caliceti P., Carofiglio T., Fornasier R., Salmaso S., Semenzato A.1: session health & medicine (2003)EuroNanoForum 2003, Trieste, Italy, 2003Link to PDF DocumentIntegrated process of design, synthesis and physicochemical characterization of nanovectors for active drug delivery: the cyclodextrin-folate-bioconjugate example
2472003Coslanich A., Fermeglia M., Ferrone M., Pricl S., Tamborini E., Oggioni M., Perrone F., Pilotti S., Delia D., Pierotti M.A.1: session health & medicine (2003)EuroNanoForum 2003, Trieste, Italy, 2003Link to PDF DocumentHow the Angstrom modifies the nano: effect of point mutations on the nanodimensional structure of human TP53 point mutations
2322003Pricl S., Fermeglia M., Ferrone M., Manfredini S., Angusti A., Di Santo R., Frecer V., Miertus S.1:1 (2003)FOMMS2003, Foundation of Molecular Modelling and Simulation, Keyston Resort, CO, USA, (2003)Link to PDF DocumentComputer-assisted design of new, potential HCV inhibitors
2422003S. Pricl, A. Coslanich, M. Fermeglia, M. Ferrone, M. Merzek, A. Angusti, N. Ciliberti, E. Durini, S. Manfredini, Chiara Musiu, Massimo Mura, Roberta Loddo, and P. La Colla1: 30-31 (2003)HEP_DART 2003, Kanaui Island (Hawaii), US 2003Link to PDF DocumentSynthesis of a New Series of Nucleoside Analogs with Antiflaviviridae Activity and Their Interaction with RNA-Dependent RNA-Polymerase
2392003F. Felluga, G. Pitacco, E. Valentin, A. Coslanich, M. Fermeglia, M. Ferrone, and S. Pricl14: 3385-3399 (2003)Tetrahedron: AsymmetryLink to PDF DocumentStudying enzyme enantioselectivity using combined ab initio and free energy calculations: alfa-chymotrypsin and methyl cis- and trans-5-oxo-2-pentylpirrolidine-3-carboxylates
1942002Ferrone,M., Fermeglia, M., Pricl, S.1: 323-325 (2002)16th European Conference on Thermophysical Properties, IC London UK, 2002Link to PDF DocumentChemical Engineering at the edge of life science. Selected cases of molecular simulations and free-energy calculations for biological and medical applications.
2042002Fermeglia, M., Ferrone, M., Pricl, S., Lodi, A., Caliceti, P., Salmaso, S., Fornasier, R.CD 1: MEDI 87 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentSynthesis, characterization and molecular modeling of a cyclodextrin-bioconjugate as anticancer drug
2052002Pricl S., Fermeglia M., Ferrone M., Tamborini E., Oggionni M., Perrone F., Delia D., Pilotti S., Pierotti M.A.CD 1: MEDI 234 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentDetailed Computational Study of Point Mutations of the TP53 Tumor-Suppressor Protein
2072002Pricl S., Felluga F., Pitacco G., Valentin E., Ferrone M.CD 1: ORGN 500 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentEnantiomerically pure beta,gamma-disubstituted gamma-lactams: Enzyme-mediated synthesis and computational studies
2082002Manfredini S., Augusti A., Durini E., Vertuani S., Nalin F., Verri A., Spadari S., Focher F., Solaroli N., De Clercq E., Balzarini J., Ferrone M., Pricl S.CD 1: MEDI 38 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentRibonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates
2092002Di Santo R., Costi R., Artico M., Fermeglia M., Ferrone M., Lodi A., Manfredini S., Pricl S.1:215-216 (2002)23rd International symposium on the chemistry of natural products (ISCNP-23), Firenze, I, 28/7-2/8, 2002Link to PDF DocumentProbing the activity of diketoacis as HCV NS5B polymerase inhibitors via detailed molecular modeling
2032002Ferrone M., Fermeglia M., Pricl S., Tamborini E., Oggioni M., Perrone F., Delia D., Pilotti S. and Pierotti M.1: 5 (2002)4° Convegno FISV, Riva del Garda (TN), I, 2002Link to PDF DocumentHuman TP53 point mutations: structural analysis by molecular modelling
2182002Artico M., Costi R., Di Santo R., Fermeglia M., Ferrone M., Manfredini S., Pricl S.CD 1: 245g (2002)AIChE annual meeting 2002, Indianapolis, USALink to PDF DocumentCan inhibitors of HIV integrase work on HCV polymerase?
2192002Pricl S., Fermeglia M., Ferrone M., Tamborini E., Oggionni M., Perrone F., Pilotti S., Delia D., Pierotti M.A.CD 1: 299c (2002)AIChE annual meeting 2002, Indianapolis, USALink to PDF DocumentDetailed Molecular Modeling of Point Mutations of P53
1752002Fermeglia M., Ferrone M., Pricl S10: 2471-2478 (2002)Bioorganic & Medicinal ChemistryLink to PDF DocumentComputer-aided simulation of a dendrimer with a protoporphyrinic core as potential, novel hemoprotein mimic.
2062002De Nardi P.G., Fermeglia M., Ferrone M., Frecer V., Kabelac M., Miertuš S., Pricl S.1: 10-11 (2002)Controlled Release Society CRS-Italian Chapter WORKSHOP su Bioconiugazione, Padova, Italy, 2002Link to PDF DocumentModellazione molecolare e progettazione di nuovi inibitori della serin proteasi NS3 del virus dell’HCV
2132002Fermeglia M., Ferrone M., Pricl S.1: 11-12 (2002)Controlled Release Society CRS-Italian Chapter WORKSHOP su Ciclodestrine, prorietà e applicazioni, Padova, Italy, 2002Link to PDF DocumentModelllazione molecolare e calcoli di energia libera di binding per complessi di inclusione ciclodestrina-farmaci antitumorali
2142002Pricl S., Fermeglia M., Ferrone M., Lodi A., Caliceti P., Salmaso S., Fornasier R.1: 17-18 (2002)Controlled Release Society CRS-Italian Chapter WORKSHOP su Ciclodestrine, prorietà e applicazioni, Padova, Italy, 2002Link to PDF DocumentA cyclodextrin-bioconjugate as carrier for anticancer drugs: from synthesis to molecular modeling
1902002Manfredini, S., Solaroli, N., Porcu, L., Angusti, A., Durini, E., Vertuani, S., Verri, A., Spadari, S., Focher, F., Ferrone, M., Pricl, S., De Clercq, E., Balzarini, J.1:315-318 (2002)Proceedings of the 15th International Conference on Antiviral Research (ICAR), Prague, Czech Republic, March 17-21, 2002Phosphonoacetic Acid (PPA) Ester and Amide Bioisosters of Ribofuranosylnucleoside Diphosphates as Potential Ribonucleotide Reductase Inhibitors: Design, Synthesis and Activity.
1892002Felluga, F., Fermeglia, M., Ferrone, M., Pitacco, G., Pricl, S., Valentin, E.13: 475-489 (2002)Tetrahedron: AsymmetryLink to PDF DocumentComputational studies on the enantioselectivity of alpha-chymotrypsin towards beta-carbomethoxy-gamma-lactams.
2152002Angusti A., Manfredini S., Veronese A. C., Durini E., Vertuani S., Nalin F., Solaroli N., Pricl S., Ferrone M., Mura M., Musiu C., Piano M. A., Poddesu B., Marturana F., La Colla P.CD 1:1(2002)XVI Convegno Nazionale Divisione Chimica Farmaceutica della Società Chimica Italiana, Sorrento, 18-22/9, 2002Progettazione, sintesi ed attività biologica di analoghi nucleosidici ad attività antiflaviviridae
1622001M. Fermeglia, A. Lodi, S. PriclAIChE national meeting 2001, Rino, USALink to PDF DocumentCyclodextrin as a template for molecular assembly: inclusion complexes with anti - cancer drugs
1632001M. Fermeglia, M. Fratta, S. PriclAIChE national meeting 2001, Rino, USALink to PDF DocumentBSE prion fragment (90-231): pH induced conformational changes and binding with potential inhibitors by molecular dynamics
1652001Fermeglia M., Ferrone M., Pricl S.AIChE national meeting 2001, Rino, USALink to PDF DocumentBiotechnological dendrimers with a protopophynic core: a molecular dynamic study
1802001Felluga, F., Pricl, S.AIChE national meeting 2001, Rino, USALink to PDF DocumentMolecular Simulation of receptor/substrate interaction: the case of alpha-chymotrypsyn and beta-carbomethoxy-gamma-lactems.
1812001De Nardi, P., Fermeglia, M., Pricl, S., Frecer, V., Miertus, S.AIChE national meeting 2001, Rino, USALink to PDF DocumentComputer design of new inhibitors of hepatitis C virus enzymes.
1822001Gelmetti, S., Fermeglia, M., Pricl, S.AIChE national meeting 2001, Rino, USALink to PDF DocumentModeling of molecular interactions and inclusion phenomena of aminoacids and nucleotides in a synthetic dendrimer.
1772001Fermeglia, M., Ferrone, M., Gelmetti, S., Pricl, S.,55: 19-26 (2001)AIM MagazineLink to PDF DocumentI dendrimeri, un esempio di molecole biotecnologiche.
1472001S. Pricl, M. Fermeglia45: 23-33 (2001)Carbohydrate PolymersLink to PDF DocumentMolecular simulations of host-guest inclusion compounds: an approach to the lactodendrimers case
1842001Felluga, F., Pitacco, G., Prodan, M., Pricl, S., Visintin, M., Valentin, E.12: 3241-3249 (2001)Tetrahedron: AsymmetryLink to PDF DocumentA chemoenzymatic approach to the synthesis of enantiomerically pure aza analogues of paraconic acid methyl ester and both enantiomers of methyl beta-proline.
1682001Pricl S., Fermeglia M., Fratta M., Forloni G., D'Ursi P.1:555-558 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentStudio dell'interazione di potenziali inibitori con il prione PRP (90-231) della BSE tramite tecniche di dinamica molecolare
1692001Pricl S., Fermeglia M., Lodi A.1:691-694 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentSimulazione molecolare di complessi host-guest: applicazione al caso ciclodestrine - farmaci antitumorali
1702001Pricl S., Fermeglia M., Ferrone M.CD 1: 535-538 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentDendrimeri biotecnologici a nucleo protoporfirinico: studio di dinamica molecolare
1732001Pricl S., Fermeglia M., Mazzurco A.1:706-709 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentModellazione molecolare della complessazione di fans in ciclodestrine modificate
1782001Pricl, S., Felluga, F.1:37-40 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentSimulazione molecolare delle interazioni recettore/substrato: il caso dell’alfa-chimotripsina e i beta-carbometossi-gamma-lattami
991996Fermeglia M., Fele L.www.egc.ac.uk (1996)EGC2 Virtual Conference, Internet, 1997Protein separation by partitioning in poly(ethylene glycol) + dextran + water.
1021996Fele L., Fermeglia M.41: 331-334 (1996)Journal of Chemical & Engineering DataLink to PDF DocumentPartition of proteins in poly(ethylene glycol) - dextran - water system at 298 K.
941995Fermeglia M.1:1(1995)Impiego dei simulatori nei processi chimici, Padova, Italy, 1995La cristallizzazione nell' industria farmaceutica: simulazione di processo.
871994Fermeglia M., Fele L.1: 92 (1994)6th European Symposium on Thermal Analysis and Calorimetry, Grado, Italy, 1994Protein partitions in aqueous two phase systems.
4281994Grassi, M., Lapasin, R., Pricl, S., Colombo, I., Adrover, A., Giona, M.1:533-534(1994)Proceedings of the Controlled Release SocietyRelease from a scleroglucan hydrogel matrix